BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19594227)

  • 1. Vanadium (vanadyl sulfate). Monograph.
    Altern Med Rev; 2009 Jun; 14(2):177-80. PubMed ID: 19594227
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes-altered gene expression in rat skeletal muscle corrected by oral administration of vanadyl sulfate.
    Willsky GR; Chi LH; Liang Y; Gaile DP; Hu Z; Crans DC
    Physiol Genomics; 2006 Aug; 26(3):192-201. PubMed ID: 16684804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vanadium compounds--a new class of therapeutic agents for the treatment of diabetes mellitus].
    Beliaeva NF; Gorodetskiĭ VK; Tochilkin AI; Golubev MA; Semenova NV; Kovel'man IR
    Vopr Med Khim; 2000; 46(4):344-60. PubMed ID: 11075417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new orally active antidiabetic vanadyl complex--bis(alpha-furancarboxylato)oxovanadium(IV).
    Xie M; Gao L; Li L; Liu W; Yan S
    J Inorg Biochem; 2005 Feb; 99(2):546-51. PubMed ID: 15621288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of diabetic states in streptozotocin-induced type 1 diabetic rats by vanadyl sulfate in enteric-coated capsules.
    Fugono J; Yasui H; Sakurai H
    J Pharm Pharmacol; 2005 May; 57(5):665-9. PubMed ID: 15901357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of vanadyl sulfate on kidney in experimental diabetes.
    Yanardag R; Bolkent S; Karabulut-Bulan O; Tunali S
    Biol Trace Elem Res; 2003 Oct; 95(1):73-85. PubMed ID: 14555801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-diabetic effects of sodium 4-amino-2,6-dipicolinatodioxovanadium(V) dihydrate in streptozotocin-induced diabetic rats.
    Li M; Smee JJ; Ding W; Crans DC
    J Inorg Biochem; 2009 Apr; 103(4):585-9. PubMed ID: 19203797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative assessment of cell mechanisms of the antidiabetic action of a new organic derivative of oxovanadium(IV) and vanadyl sulfate].
    Aleeva GN; Kiiasov AP; Burykin IM; Khafiz'ianova RKh
    Eksp Klin Farmakol; 2004; 67(3):42-4. PubMed ID: 15341067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vanadium derivatives--a new source of antidiabetic drugs].
    Dănilă G; Lupaşcu D
    Rev Med Chir Soc Med Nat Iasi; 1999; 103(3-4):74-7. PubMed ID: 10756929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vanadyl sulfate protects against streptozotocin-induced morphological and biochemical changes in rat aorta.
    Akgün-Dar K; Bolkent S; Yanardag R; Tunali S
    Cell Biochem Funct; 2007; 25(6):603-9. PubMed ID: 16892454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the hypoglycemic action of vanadium compounds related to the suppression of feeding?
    Huang M; Wu Y; Wang N; Wang Z; Zhao P; Yang X
    Biol Trace Elem Res; 2014 Mar; 157(3):242-8. PubMed ID: 24446192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of vanadyl sulfate administration on sugar metabolism in the senescent rat.
    Bergamini E; De Tata V; Novelli M; Cavallini G; Masiello P; Gori Z
    Ann N Y Acad Sci; 1994 Jun; 717():174-9. PubMed ID: 8030834
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oral antidiabetics].
    Glombik H; Weyer R
    Prog Drug Res; 1986; 30():281-343. PubMed ID: 3544046
    [No Abstract]   [Full Text] [Related]  

  • 14. [The vanadium compounds: chemistry, synthesis, insulinomimetic properties].
    Fedorova EV; Buriakina AV; Vorob'eva NM; Baranova NI
    Biomed Khim; 2014; 60(4):416-29. PubMed ID: 25249525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vanadium and diabetes.
    Poucheret P; Verma S; Grynpas MD; McNeill JH
    Mol Cell Biochem; 1998 Nov; 188(1-2):73-80. PubMed ID: 9823013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potentiality of vanadium in medicinal applications.
    Rehder D
    Future Med Chem; 2012 Sep; 4(14):1823-37. PubMed ID: 23043479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic study and trial for preparation of enteric-coated capsule containing insulinomimetic vanadyl compounds: implications for clinical use.
    Sakurai H; Fugono J; Yasui H
    Mini Rev Med Chem; 2004 Jan; 4(1):41-8. PubMed ID: 14754442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic potential of vanadium in treating diabetes mellitus].
    Sakurai H
    Clin Calcium; 2005 Jan; 15(1):49-57. PubMed ID: 15632473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vanadium compounds for the treatment of human diabetes mellitus: A scientific curiosity? A review of thirty years of research.
    Domingo JL; Gómez M
    Food Chem Toxicol; 2016 Sep; 95():137-41. PubMed ID: 27417449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contractile effects of nanomolar concentrations of vanadyl sulphate on gastric smooth muscle cells isolated from normal or diabetic rats.
    Soulié ML; Cadène A; Magous R; Serrano JJ; Bali JP; Teissèdre PL; Cros G
    Fundam Clin Pharmacol; 1996; 10(1):60-1. PubMed ID: 8900502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.